HEREDITARY DEFICIENCY OF FACTOR XIII – LACKY-LORANDE FACTOR

Authors

  • Juraeva N.T RSSPMC Hematology Ministry of Health of the Republic of Uzbekistan. EMU University Author
  • Radjabova S.O. RSSPMC Hematology Ministry of Health of the Republic of Uzbekistan. EMU University Author

Keywords:

Rare blood coagulation disorder, factor XIII deficiency, factor XIII concentrate, cephalohematoma, hemarthrosis.

Abstract

Congenital factor XIII (FXIII) deficiency is a rare bleeding disorder characterized by muscle or mucocutaneous bleeding with life-threatening intracranial hemorrhage (ICH), especially in severe cases.  Although FXIII deficiency is rare, it is characterized by varying bleeding manifestations depending on the magnitude of the deficiency.  Congenital FXIII deficiency with a level of less than 1% can be found in children with prolonged bleeding from the umbilical cord stump, as well as with prolonged bleeding after trauma. Factor XIII (FXIII) is activated by thrombin to produce transglutaminase (FXIIIa), which stabilizes clot formation by cross-linking fibrin monomers and antifibrinolytic proteins. The molecular basis of FXIII deficiency is characterized by a high degree of heterogeneity, which results in variable clinical manifestations of the disease. More than 60 FXIII mutations have been identified in the current literature.

References

1. Carcao M., Altisent C., Castaman G., Fukutake K., Kerlin B.A., Kessler C., Lassila R., Nugent D., Oldenburg J., Garly M.L., Rosholm A., Inbal A. Recombinant FXIII (rFXIII-A2) Prophylaxis Prevents Bleeding and Allows for Surgery in Patients with Congenital FXIII A-Subunit Defi ciency. Thromb Haemost. 2018;118(3):451–60. doi: 10.1055/s-0038-1624581.

2. Dorgalaleh A., Naderi M., Hosseini M.S., Alizadeh S., Hosseini S., Tabibian S., Eshghi P. Factor XIII defi ciency in Iran: a comprehensive review of the literature. Semin Thromb Hemost. 2015;41(3):323–9. doi: 10.1055/s-0034-1395350.

3. Dorgalaleh A., Rashidpanah J. Blood coagulation factor XIII and factor XIII defi ciency. Blood Rev. 2016;30(6):461–75. PMID: 27344554.

4. Komaromi I., Bagoly Z., Muszbek L. Factor XIII: novel structural and functional aspects. J Thromb Haemost. 2011;9(1):9–20. doi: 10.1111/j.1538-7836.2010.04070.x.

5. Kohler H., Ichinose A., Seitz R., Ariens R., Muszbek L. Diagnosis and classifi cation of factor XIII defi ciencies. J Thromb Haemost. 2011;9(7):1404–6. PMID: 22946956.

6. Lassila R. Clinical Use of Factor XIII Concentrates. Semin Thromb Hemost. 2016;42(4):440–4. doi: 10.1055/s-0036-1572324.

7. Muszbek L., Bagoly Z., Cairo A., Peyvandi F. Novel aspects of factor XIII defi ciency. Curr Opin Hematol. 2011;18(5):366–72. doi: 10.1097/MOH.0b013e3283497e3e.

8. Mangla A., Hamad H., Kumar A. Factor XIII Deficiency. In:StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan. 2021 Oct 10. PMID: 32491399.

Downloads

Published

2026-01-01